| Financial Year |
March 31 2023 |
| Monetary Funds |
1,866,015,323.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
205,453,149.00 |
| Advances to Suppliers |
38,565,541.00 |
| Other Receivables |
72,474,132.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,759,618,215.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
162,597,437.00 |
| Total Current Assets |
5,452,393,202.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
40,907,944.00 |
| Investment Properties |
21,380,544.00 |
| Fixed Assetes |
5,980,383,071.00 |
| Under-construction Projects |
54,708,907.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
180,184,456.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
574,587,272.00 |
| R&D expenses |
-- |
| Goodwill |
107,163,616.00 |
| Long-Term Deferred and Prepaid Expenses |
270,188,506.00 |
| Deferred Income Tax Assets |
198,018,177.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
7,561,868,250.00 |
| Total Assets |
13,014,261,452.00 |
| Short-Term Loans |
360,070,115.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
373,831,447.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
144,533,804.00 |
| Taxes Payable |
161,231,539.00 |
| Interest Payable |
2,156,339.00 |
| Dividend Payable |
-- |
| Other payables |
329,594,016.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
156,891,827.00 |
| Other Current Liabilities |
17,348,720.00 |
| Sub-Total of Current Liabilities |
1,676,953,160.00 |
| Long-term Loans |
122,856,588.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,584,335.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
289,663,319.00 |
| Total Liabilities |
1,966,616,479.00 |
| Paid-In Capital(Or Share Stock) |
685,464,000.00 |
| Capital Surplus |
523,877,252.00 |
| Surplus Reserve |
342,732,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,326,428,198.00 |
| Minority Stockholder's Interest |
189,758,766.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,857,886,207.00 |
| Owner's Equity（Stockholder's Equity） |
11,047,644,973.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,014,261,452.00 |
